VeriChip Corporation, makers of health care-related RFID solutions, have announced the development of a new, smaller version of its human-implantable RFID microchip. The new microchip measures approximately 8 millimeters by 1 millimeter, compared to the currently marketed version’s 11 millimeter by 1 millimeter dimensions.
The new device has been developed specifically to be incorporated into Medical Components Inc.’s vascular ports. It is the product of an agreement with Medcomp, announced this March, to develop and manufacture a RFID microchip exclusively for implantation into Medcomp’s vascular access medical devices. The agreement is reported to be worth over $3 million over five-years.
The completion of the agreement between VeriChip and Medcomp is contingent upon FDA approval of the vascular pump containing the microchip.